Improved detection of aneuploidy in malignant melanoma using multiparameter flow cytometry for s100 protein and DNA content

Hideko Kamino, Howard Ratech

Research output: Contribution to journalArticle

13 Scopus citations


DNA aneuploidy has been demonstrated to be an independent parameter of prognostic significance in malignant melanomas. In order to improve the detection of DNA aneuploidy in malignant melanomas, and to minimize diploid non-tumor cells in the sample, we developed a two-color staining strategy for S 100 protein and DNA content in paraffin embedded samples. The ability to detect aneuploidy, defined as DNA ploidy index ≤ 0.90 or ≥ 1.10, in 37 stage I malignant melanoma samples by flow cytometry analysis was significantly improved from 10.8% of cases using traditional one-color analysis for DNA content only (propidium iodide) to 32.4% of cases using two-color analysis for simultaneous measurement of both DNA (propidium iodide) and S100 protein (fluorescein conjugated antibody) (Chi-square with Yates' correction; p < 0.05). The largest increase in sensitivity was found in level I and II melanomas less than or equal to 0.76 mm in thickness. In addition, we report the new observation that multiple S100 protein-positive subpopulations were found significantly more frequently in malignant melanomas (23/37 cases) than in compound melanocytic nevi (5/22 cases) (Chi-square with Yates' correction; p < 0.01). These findings suggest that there is a previously unsuspected degree of tumor heterogeneity even in thin, presumably early, malignant melanomas.

Original languageEnglish (US)
Pages (from-to)392-396
Number of pages5
JournalJournal of Investigative Dermatology
Issue number3
Publication statusPublished - Sep 1989


ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Dermatology
  • Cell Biology

Cite this